Nurse Practitioner · Saint Louis, MO
NPI
1003396334
Since 2018
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
620 S Taylor Ave, Div Im Infectious Disease, Ste 100
Saint Louis, MO, 63110
Phone (314) 362-9098
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
427 services
Medicare patients, 2024
210
Average age 69
Drug cost, 2024
$1.8M
2,064 prescriptions
Company payments, 2025
$204
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel E Obrien was code 99214 (office e&m - established), 216 times for 158 patients. In total Rachel E Obrien billed 427 services in 22 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 216 | 158 | $73.96 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 75 | 63 | $10.57 | $793 |
| 99442 Telephone Services | Office | 23 | 21 | $52.65 | $1,211 |
| 99441 Telephone Services | Office | 22 | 20 | $29.82 | $656 |
| 99204 Office E&M - New | Office | 11 | 11 | $89.21 | $981 |
By year: 2022 $18K for 272 services; 2023 $27K for 386 services; 2024 $24K for 427 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachel E Obrien prescribed most often to Medicare patients was Doxycycline Hyclate, with 257 prescriptions and refills. In total Rachel E Obrien wrote 2,064 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 257 | 475 | 64 | $11K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 171 | 294 | 46 | $7,770 |
| Cefadroxil Generic | 93 | 176 | 26 | $4,667 |
| Methenamine Hippurate Generic | 92 | 128 | 16 | $5,867 |
| Amoxicillin Generic | 88 | 171 | 25 | $1,263 |
| Fluconazole Generic | 87 | 117 | 24 | $3,965 |
| Cephalexin Generic | 87 | 141 | 25 | $2,139 |
| Azithromycin Generic | 80 | 96 | 39 | $1,190 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 73 | 131 | 22 | $1,416 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 72 | 74 | Under 11 | $308K |
| Rifabutin Generic | 61 | 69 | 12 | $37K |
| Ethambutol Hcl Generic | 57 | 73 | 11 | $3,451 |
| Ciprofloxacin Hcl Generic | 52 | 95 | 20 | $2,664 |
| Fosfomycin Tromethamine Generic | 49 | 62 | 12 | $12K |
| Sivextro Tedizolid Phosphate | 36 | 36 | Under 11 | $449K |
Brand drugs: 396 claims; generic drugs: 1,668 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel E Obrien $204 ($204 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbvie Inc. with $76.43.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.